|
|
|
Volumn , Issue No 284, 1997, Pages 2-3
|
|
FDA approves new kind of lymphoma treatment. Food and Drug Administration.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
RITUXIMAB;
ARTICLE;
B CELL LYMPHOMA;
CLINICAL TRIAL;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
UNITED STATES;
ANTIBODIES, MONOCLONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CLINICAL TRIALS;
DRUG APPROVAL;
HUMANS;
LYMPHOMA, B-CELL;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 0031555233
PISSN: 10524207
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (42)
|
|
References (0)
|
